"Exploring Promising Drug Treatments for Alzheimer's Disease"
TL;DR
Ohio State University researchers are conducting a drug trial for Lecanemab, a drug that slows the progression of Alzheimer's symptoms, to see if it can prevent the disease from developing in high-risk individuals. NBC4 Anchor Colleen Marshall, at high risk due to her family history, volunteered for the study but did not qualify due to low amyloid levels. The drug is currently approved for those with mild Alzheimer's, and researchers are exploring its potential for high-risk individuals before symptoms appear.
- Ohio State continues study into drug to slow Alzheimer’s NBC4 WCMH-TV
- Psychology class: New studies find benefits in very early drug treatment of Alzheimer's Financial Times
- New Advances in Alzheimer's Treatments - Thursday, February 8, 2024, 6 p.m. to 7 p.m. San Diego Reader
- Alzheimer's Disease Treatment Realities and Risks Alzheimer's San Diego
- Promising Advancements in Alzheimer's Treatment: A Neurologist's Insight BNN Breaking
Want the full story? Read the original reporting
Read on NBC4 WCMH-TV